On Friday, Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART), surged 11.40% to $65.48, hitting its highest level.
Integra LifeSciences, declared the introduction of the new MAYFIELD(R) 2 system for rigid cranial fixation. The MAYFIELD 2 system will be featured at the Integra LifeSciences exhibition booth at the American Association of Neurological Surgeons Annual Meeting, May 2-6, 2015, in Washington, D.C.
The MAYFIELD 2 system comprises of a new Skull Clamp, together with a new Base Unit. The MAYFIELD 2 Skull Clamp is composed of a new stronger and lighter weight material. It comprises an raised amount of off-set ratcheting teeth for more precise closure, an I-beam for smoother closure, and a new dual button release for easier removal. The MAYFIELD 2 Base Unit features a powder-coated finish, which allows automatic washing, and a swivel adaptor that does not require any additional tools for adjustment.
MAYFIELD cranial stabilization systems are used worldwide in over 200,000 neurosurgical procedures annually. These procedures comprise craniotomy for tumor removal, treatment of head trauma injuries, pediatric disorders such as hydrocephalus, biopsies, cancer removal, cerebrovascular disorders such as aneurysms, posterior cervical spine conditions and neurodegenerative disorders such as Parkinson’s disease or epilepsy. Integra is a leading provider of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neuro-trauma and related neurocritical care.
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery.
At the end of Friday’s trade, Shares of Century Aluminum Co. (NASDAQ:CENX), jumped 13.23% to $14.60.
Century Aluminum Company, stated net income of $73.8 million ($0.76 per common share) for the first quarter of 2015. Results comprise $6.5 million ($0.07 per common share) for an unrealized gain on fair value of contingent consideration related to the acquisition of the remaining 50.3% interest of Mt. Holly and were negatively influenced by $1.6 million ($0.02 per common share) for signing bonuses related to a new labor agreement in Iceland and $1.0 million ($0.01 per common share) related to the separation of a former senior executive.
Sales for the first quarter of 2015 were $587.9 million contrast with $420.8 million for the first quarter of 2014. Shipments of primary aluminum for the first quarter of 2015 were 245,258 tonnes contrast with 206,785 tonnes shipped in the first quarter of 2014.
For the first quarter of 2014, Century stated a net loss of $20.1 million ($0.23 per common share). Cost of sales for the quarter comprised of a benefit of $5.5 million related to deferred power contract liability amortization. Results were negatively influenced by a $3.1 million charge for raised legal reserves.
Net cash offered by operating activities in the first quarter of 2015 was $116.3 million as contrast to a net use of cash of $10.7 million in the first quarter of 2014. During the first quarter of 2015, Century raised its share repurchase program authorization to $130 million and attained 1.2 million shares of common stock for a total cost of $19.4 million.
Century Aluminum Company, together with its auxiliaries, produces primary aluminum in the United States and Iceland. It produces standard grade and value-added primary aluminum products; and carbon products, such as anodes and cathodes. The company was founded in 1981 and is headquartered in Chicago, Illinois.
DURECT Corporation (NASDAQ:DRRX), ended its last trade with 11.68% gain, and closed at $2.20.
DURECT Corporation, declared financial results for the first quarter of 2015. Total revenues were $4.8 million and net loss was $4.9 million for the three months ended March 31, 2015 as contrast to total revenues of $6.3 million and net loss of $3.6 million for the three months ended March 31, 2014.
At March 31, 2015, the company had cash and investments of $29.8 million, contrast to cash and investments of $34.9 million at December 31, 2014. Subsequent to quarter-end, DURECT raised net proceeds of $10.1 million from the sale of 5.4 million shares in the open market at an average price of $1.94 per share through use of our ATM facility. At March 31, 2015, we had $19.8 million in long term debt.
DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceuticals products based on its proprietary drug formulations and delivery platform technologies in the United States, Europe, Japan, and internationally.
Finally, Teradyne Inc. (NYSE:TER), closed at $20.30, with 11.23% gain.
Teradyne, stated revenue of $342 million for the first quarter of 2015 of which $271 million was in Semiconductor Test, $37 million in System Test and $34 million in Wireless Test. On a non-GAAP basis, Teradyne’s net income in the first quarter was $37.6 million, or $0.17 per diluted share, which excluded attained intangible asset amortization, gain on the sale of an equity investment and discrete income tax adjustments. GAAP net income for the first quarter was $32.8 million or $0.15 per share.
Orders in the first quarter of 2015 were $490 million of which $397 million were in Semiconductor Test, $66 million in System Test and $27 million in Wireless Test.
Teradyne also declared it has reached a credit agreement for a 5 year, senior secured credit facility of $350 million to be accessible for general corporate purposes and working capital. Teradyne has not borrowed funds under this facility to date.
Guidance for the second quarter of 2015 is revenue of $470 million to $500 million, with non-GAAP net income of $0.42 to $0.48 per diluted share and GAAP net income of $0.37 to $0.43 per diluted share. Non-GAAP guidance excludes attained intangible asset amortization and the related tax impact on non-GAAP adjustments.
Teradyne, Inc. provides automatic test equipment worldwide. The company’s Semiconductor Test segment designs, manufactures, sells, and supports semiconductor test products and services for wafer level and device package testing in automotive, industrial, communications, consumer, computer and electronic game applications, and others.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
